Harnessing the power of single-cell multiomics to uncover the complexities of acute promyelocytic leukemia
By leveraging the use of biological materials from acute promyelocytic leukemia (APL) patients and transgenic PML-RARA murine models, we aim to study the molecular mechanisms underlying coagulopathy in APL.